Differential Elevation of Inflammation and CD4+ T Cell Activation in Kenyan Female Sex Workers and Non-Sex Workers Using Depot-Medroxyprogesterone Acetate
- PMID: 33717049
- PMCID: PMC7949914
- DOI: 10.3389/fimmu.2020.598307
Differential Elevation of Inflammation and CD4+ T Cell Activation in Kenyan Female Sex Workers and Non-Sex Workers Using Depot-Medroxyprogesterone Acetate
Abstract
Background: Depot Medroxyprogesterone (DMPA) is one of the most widely used contraceptives in Sub-Saharan Africa where HIV incidence is high. We explored the effect of DMPA on the activation of HIV cellular targets and inflammation as a possible mechanism of increased HIV risk with DMPA use. Since sex work is known to affect the immune system, this study aimed to understand the effect of DMPA on the immune system among sex workers and non-sex worker women.
Methods: Twenty-seven DMPA-using HIV seronegative female sex workers (FSW) and 30 DMPA-using HIV seronegative non-sex worker (SW) women were enrolled in the study. Twenty-four FSWs and 30 non-sex workers who were not using any hormonal contraception (no HC) were recruited as controls. Blood and cervico-vaginal samples were collected from all participants and assayed for T cell activation and proinflammatory cytokines.
Results: Among no HC users, sex workers had lower expression of CD38 and CD69 on blood-derived CD4+ T cells along with lower CD4+CCR5+ cells frequency in the endocervix. Plasma MCP-1, TNFα and IL-17 also had reduced expression in FSW not using HC. Non-sex workers using DMPA had elevated proportions of blood-derived CD4+CD38+, CD4+CD69+ and CD4+HLA-DR+ T cells relative to non-sex workers who were not taking any HC. DMPA-using non-sex workers also had an increased level of plasma interferon gamma (IFN-γ), monokine induced by interferon-γ (MIG) and sCD40L, alongside higher proportion of CD4+CD38+ and CD4+CD69+ T cells at the cervix compared to non-sex workers no-HC controls., Finally, non-sex workers and FSWs using DMPA had similar levels of genital and peripheral CD4+ T cell activation and inflammation.
Conclusion: DMPA increased inflammation and expression of activation markers on potential HIV target cells in non-sex workers. These data show that DMPA is a strong immune modulator and its use counteracts the decreased immune activation associated with sex work. These findings suggest that inflammation and increased HIV target cells in blood and at the genital tract may be mechanisms by which DMPA increases susceptibility to HIV.
Keywords: DMPA; HIV target cells; T-cell activation; commercial sex workers; endocervix; inflammation.
Copyright © 2021 Omollo, Lajoie, Oyugi, Wessels, Mwaengo, Kimani, Kaushic and Fowke.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures









Similar articles
-
Update on the Impact of Depot Medroxyprogesterone Acetate on Vaginal Mucosal Endpoints and Relevance to Sexually Transmitted Infections.Curr HIV/AIDS Rep. 2023 Aug;20(4):251-260. doi: 10.1007/s11904-023-00662-0. Epub 2023 Jun 21. Curr HIV/AIDS Rep. 2023. PMID: 37341916 Free PMC article. Review.
-
Increased Cervical CD4+CCR5+ T Cells Among Kenyan Sex Working Women Using Depot Medroxyprogesterone Acetate.AIDS Res Hum Retroviruses. 2019 Mar;35(3):236-246. doi: 10.1089/AID.2018.0188. Epub 2019 Jan 24. AIDS Res Hum Retroviruses. 2019. PMID: 30585733 Free PMC article.
-
Impact of etonogestrel implant use on T-cell and cytokine profiles in the female genital tract and blood.PLoS One. 2020 Mar 26;15(3):e0230473. doi: 10.1371/journal.pone.0230473. eCollection 2020. PLoS One. 2020. PMID: 32214321 Free PMC article. Clinical Trial.
-
Effect of injectable progestin-only contraceptives, depot medroxyprogesterone acetate and norethisterone enanthate, on cytokine production during T-cell activation.Am J Reprod Immunol. 2021 Jul;86(1):e13405. doi: 10.1111/aji.13405. Epub 2021 Mar 5. Am J Reprod Immunol. 2021. PMID: 33609312 Clinical Trial.
-
An updated review on the effects of depot medroxyprogesterone acetate on the mucosal biology of the female genital tract.Am J Reprod Immunol. 2021 Sep;86(3):e13455. doi: 10.1111/aji.13455. Epub 2021 Jun 12. Am J Reprod Immunol. 2021. PMID: 33991137 Free PMC article. Review.
Cited by
-
Glucocorticoids and medroxyprogesterone acetate synergize with inflammatory stimuli to selectively upregulate CCL20 transcription.Mol Cell Endocrinol. 2023 Mar 1;563:111855. doi: 10.1016/j.mce.2023.111855. Epub 2023 Jan 13. Mol Cell Endocrinol. 2023. PMID: 36646303 Free PMC article.
-
Update on the Impact of Depot Medroxyprogesterone Acetate on Vaginal Mucosal Endpoints and Relevance to Sexually Transmitted Infections.Curr HIV/AIDS Rep. 2023 Aug;20(4):251-260. doi: 10.1007/s11904-023-00662-0. Epub 2023 Jun 21. Curr HIV/AIDS Rep. 2023. PMID: 37341916 Free PMC article. Review.
-
The Penis, the Vagina and HIV Risk: Key Differences (Aside from the Obvious).Viruses. 2022 May 27;14(6):1164. doi: 10.3390/v14061164. Viruses. 2022. PMID: 35746636 Free PMC article. Review.
-
Comparison of Female Genital Tract Cytokine and Microbiota Signatures Induced by Initiation of Intramuscular DMPA and NET-EN Hormonal Contraceptives - a Prospective Cohort Analysis.Front Immunol. 2021 Dec 9;12:760504. doi: 10.3389/fimmu.2021.760504. eCollection 2021. Front Immunol. 2021. PMID: 34956191 Free PMC article. Clinical Trial.
-
Systems analysis reveals differential expression of endocervical genes in African women randomized to DMPA-IM, LNG implant or cu-IUD.Clin Immunol. 2023 Oct;255:109750. doi: 10.1016/j.clim.2023.109750. Epub 2023 Sep 3. Clin Immunol. 2023. PMID: 37660744 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous